Abstract 328: Targeting Mcl-1 enhances DNA replication stress sensitivity for cancer therapy
Guo Chen(Jinan University), Xingming Deng(Emory University), Sarah W. Satola, Gabriel Sica(Emory University), Walter J. Curran(Piedmont Cancer Institute), Andrew T. Magis(Institute for Systems Biology), Dongkyoo Park(Central South University), David S. Yu(Emory University), Paul W. Doetsch(Emory University), Ke Xu(Fujian Medical University), Suresh Ramalingam(Emory University), Taofeek K. Owonikoko(UPMC Hillman Cancer Center)
Cited by 2
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
|The Lancet|2004|2.4k
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
|Journal of Clinical Oncology|2013|1.1k
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
|New England Journal of Medicine|2016|1k
A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1,960 Patients in the RTOG Database
|International Journal of Radiation Oncology*Biology*Physics|2007|1k